ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
STAT3 |
|
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
119.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
119.000 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
119.000 |
Evidence |
|
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
HES6 |
HES6: Transcription cofactor HES-6 |
119.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
SYK |
SYK: Tyrosine-protein kinase SYK |
119.000 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
119.000 |
Evidence |
|
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
119.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
119.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
119.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
LYN |
LYN: Tyrosine-protein kinase Lyn |
119.000 |
Evidence |
|
HCK |
IPI00029769 |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
119.000 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
119.000 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
119.000 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
STAT3 |
|
119.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
CSK |
CSK: Tyrosine-protein kinase CSK |
119.000 |
Evidence |
|
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
BID |
BID: BH3-interacting domain death agonist |
119.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
119.000 |
Evidence |
|
WASPIP |
IPI00552369 |
CRK |
IPI00399054 |
118.000 |
Evidence |
|
DIAPH1 |
Diaphanous 1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
118.000 |
Evidence |
|
FGA |
IPI00021885 |
F13B |
F13B: Coagulation factor XIII B chain precursor |
118.000 |
Evidence |
|
H2AFX |
H2AFX, H2AX: Histone H2A.x |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
118.000 |
Evidence |
|